| Application no. and date | 14775569.8 (espacenet) (Federated) (European Patent Register), 20140313 | | Patent/reg. no. and date | DK/EP 2968294, 20190501 | | Publication date | 20160120 | | Priority no. and date | US 201361779828 P, 20130313, US 201361904718 P, 20131115 | | EP pub. no. and date |
EP 2968294 20160120 | | Effective date | | | Applicant/owner | Oncoceutics, Inc., 3675 Market Street
Suite 200
Philadelphia, PA 19104, US | | Applicant ref. no. | | | Inventor | STOGNIEW, Martin, 1870 Ferguson Ln.
Blue Bell, PA 19422, US,
NALLAGANCHU, Bhaskara, Rao, 99 Norstrand Road
Hillsborough, NJ 08852, US,
POTTORF, Richard, S., 7550 Prairie View Dr.
Indianapolis, IN 46526, US,
OLSON, Gary, L., 7 Deer Park Drive
Suite D
Monmouth Junction, NJ 08852, US,
ALLEN, Joshua, E., 129 Tremont St
Cambridge, MA 02139, US | | Representative | Potter Clarkson A/S, Regnbuepladsen 7, 1550 København V, DK | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61K 31/519 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , C07D 471/14 (2006.01) | | Title | 7-BENZYL-10-(2-METHYLBENZYL)-2,6,7,8,9,10-HEXAHYDROIMIDAZO[1,2-A]PYRIDO[4,3-D]PYRIMIDIN-5(3H)-ON TIL ANVENDELSE I BEHANDLINGEN AF CANCER | | Int. application no. | US2014025885 | | Int. publication no. | WO2014160130 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
